Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Erick Gamelin currently holds 94,946 shares of Acrivon Therapeutics, Inc. (ACRV), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Erick Gamelin has been a net neutral trader of ACRV stock. They have purchased $0 and sold $0 worth of shares.
Erick Gamelin's most recent insider trade was on Mar 1, 2026, when they sold 94,946 shares at $0.00 per share.
Erick Gamelin serves as Executive at Acrivon Therapeutics, Inc. (ACRV). They have executed 9 insider transactions totaling $0 over their tenure at the company.
Erick Gamelin holds the position of Executive at Acrivon Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 3 years and currently hold a stake valued at $0.
Erick Gamelin has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Erick Gamelin was on Nov 14, 2023, when they sold $7.1K worth of ACRV shares. This transaction involved 1,395 shares at $5.08 per share.
Erick Gamelin currently owns 94,946 shares of Acrivon Therapeutics, Inc. (ACRV), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Erick Gamelin's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Erick Gamelin has 9 Form 4 filings on record as an insider at Acrivon Therapeutics, Inc..
Set alerts for Erick Gamelin and 40,000+ other insiders.